API Holdings, the parent company of online pharmacy PharmEasy, announced last week that it would pick up a 66.1 per cent stake in diagnostics firm Thyrocare for Rs 4,546 crore. It is the first unicorn to acquire a listed company.
- ChatGPT Mobile App Introduces Video and Screensharing Features
- India’s Forex Reserves Drop by $3.23 Billion to $654.86 Billion on 6th Dec
- Paraguayan President Santiago Pena Opens Jerusalem Embassy
- Premier Energies Planning to Establish 1 GW Manufacturing Plant in Telangana
- International Gemmological Institute (India) IPO GMP, Lot Size & Key Dates
One of the most extensive consolidations in the domestic health care space, the deal was struck in record time at the Mumbai residence of A Velumani, founder of Thyrocare. The deal is also a milestone for five friends from the Mumbai suburb of Ghatkopar, who called themselves the Ghatkopar Gujju gang and set up PharmEasy in 2015.